China Healthwise Holdings Limited provided unaudited consolidated group earnings guidance for the half year of 2022. For the period, the group expects to record a loss attributable to owners of the Company within a range of approximately HKD 15 million to approximately HKD 23 million, as compared to a profit attributable to owners of the Company of HKD 37 million for the half year of 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.067 HKD | +4.69% | +11.67% | +63.41% |
26/03 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
21/03 | China Healthwise to Widen Losses in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
+63.41% | 6.31M | |
+25.99% | 76.05B | |
-3.69% | 23.81B | |
+15.24% | 8.8B | |
+1.71% | 8.29B | |
-33.21% | 6.77B | |
+19.66% | 5.36B | |
+0.89% | 4.06B | |
-8.73% | 3.77B | |
-9.28% | 3.39B |
- Stock Market
- Equities
- 348 Stock
- News China Healthwise Holdings Limited
- China Healthwise Holdings Limited Provides Unaudited Consolidated Group Earnings Guidance for the Half Year of 2022